ACON

시간 외 거래: 3.15 -0.02 -0.63%

Aclarion Inc (ACON)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Aclarion Inc Stock (ACON) Company Profile

Aclarion Inc

Healthcare (1110)

833 275 2266

8181 ARISTA PLACE, BROOMFIELD

최신 SEC 제출 서류

ACON's Discussions on Twitter

Compare ACON vs VEEV, TEM, BTSG, HQY, WAY

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ACON Aclarion Inc	3.17	7.37M	75,700	-7.23M	-7.37M	-17.21
VEEV Veeva Systems Inc	159.09	24.73B	3.20B	908.91M	1.39B	5.4168
TEM Tempus Ai Inc	49.53	7.70B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	46.04	8.71B	12.91B	104.80M	394.69M	0.8769
HQY Healthequity Inc	81.36	6.59B	1.31B	215.20M	408.32M	2.4627
WAY Waystar Holding Corp	22.43	4.12B	1.10B	112.09M	283.19M	0.6096

Aclarion Inc 주식(ACON)의 최신 뉴스

Aclarion Inc (ACON) 재무 분석

Aclarion Inc (ACON)

Aclarion Inc Stock (ACON) Company Profile

Compare ACON vs VEEV, TEM, BTSG, HQY, WAY

Aclarion Inc 주식(ACON)의 최신 뉴스

Aclarion's AI Platform Nociscan Wins Pinnacle Award, Validating Approach to Chronic Low Back Pain Diagnosis - citybuzz -

Aclarion Receives Pinnacle Award for AI Innovation - Yahoo Finance

Aclarion (ACON) price target decreased by 69.57% to 7.14 - MSN

Take Profit: Will Opendoor Technologies Inc outperform the market in YEAR2026 Trading Recap & Verified Swing Trading Watchlist - baoquankhu1.vn

Aclarion Announces Agreement with Weill Cornell Medicine - Bitget

Aclarion establishes agreement with Weill Cornell Medicine By Investing.com - Investing.com Australia

Aclarion Partners with Weill Cornell Medicine to Expand Nociscan Use in Spine Pain Research - citybuzz -

Aclarion establishes agreement with Weill Cornell Medicine - Investing.com

Weill Cornell spine study adds Aclarion tool for chronic back pain - Stock Titan

Trading Action: How does Aclarion Inc compare to its peers2026 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video - marketscreener.com

Aclarion says one London clinic has used its back-pain scan nearly 100 times - Stock Titan

Why Aclarion Inc. stock could rally in 20262026 Short Interest & Verified Stock Trade Ideas - bollywoodhelpline.com

Aclarion (ACON) to Release Quarterly Earnings on Tuesday - Defense World

Chipmakers Recap: Will Aclarion Inc Equity Warrant outperform tech stocksMarket Activity Report & Expert Verified Movement Alerts - baoquankhu1.vn

Street Watch: Will Aclarion Inc Equity Warrant outperform tech stocksGap Up & Low Risk Investment Opportunities - baoquankhu1.vn

Aclarion (NASDAQ: ACON) seeks stockholder approval to expand equity plan to 500,000 shares - Stock Titan

ACON Should I Buy - Intellectia AI

Aclarion Inc Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - Mint

US Market Wrap: Will Aclarion Inc Equity Warrant outperform tech stocks2026 Big Picture & Daily Volume Surge Signals - baoquankhu1.vn

Is Aclarion Inc Equity Warrant stock a good dividend stock2026 Momentum & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Aug Macro: How does Aclarion Inc Equity Warrant correlate with Nasdaq2026 Growth vs Value & Fast Moving Stock Watchlists - baoquankhu1.vn

SEG Opportunity Fund (ACON) discloses 244,043 shares, 9.98% of Aclarion - Stock Titan

Aclarion (ACON): Analyst Lowers Price Target While Maintaining B - GuruFocus

Macro Review: Should I hold or sell Aclarion Inc Equity Warrant now2026 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn

Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. - Bitget

Investment Review: Is Aclarion Inc. still a buy after recent gains2026 Review & Stepwise Trade Signal Guides - baoquankhu1.vn

Targets Report: Is Aclarion Inc still a buy after recent gainsPortfolio Update Summary & Scalable Portfolio Growth Ideas - baoquankhu1.vn

Aclarion, Inc. Adopts One-Year Stockholder Rights Plan to Protect Shareholder Value and Prevent Hostile Takeovers - Minichart

Aclarion adopts one-year stockholder rights plan By Investing.com - Investing.com India

Aclarion Adopts One-Year Stockholder Rights Protection Plan - TipRanks

Aclarion (NASDAQ: ACON) sets 10% trigger in one-year rights plan - Stock Titan

Aclarion adopts one-year stockholder rights plan - Investing.com

Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan - The Manila Times

Aclarion installs 1-year takeover defense, keeps door open to fair bids - Stock Titan

Shareholder Letter From Chief Executive Officer Brent Ness - 富途牛牛

Aclarion, Inc. Pursues Insurance Reimbursement Initiatives and Reports Strong Momentum Leading into 2026 - Quiver Quantitative

Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts - Bluefield Daily Telegraph

Aclarion : Shareholder Letter from Chief Executive Officer Brent Ness - MarketScreener

Aclarion, Inc. Revolutionizes Low Back Pain Diagnosis with MR Spectroscopy and AI-Powered NOCISCAN Platform 798083 - Minichart

Published on: 2026-03-19 07:53:44 - baoquankhu1.vn

Aclarion (NASDAQ: ACON) expands NOCISCAN spine diagnostics and AI plans - Stock Titan

Aclarion 10-K: Revenue $0.076M, EPS (13.61) — Annual Report Highlights - tradingview.com

ACON: Revenue up 65.6% to $75.7K; net loss $7.2M; $22.6M raised in 2025, $10.4M in 2026 - tradingview.com

Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Published on: 2026-03-19 06:54:42 - baoquankhu1.vn

Aclarion to Present at ROTH Conference, Showcasing Nociscan Technology for Chronic Back Pain Diagnosis - citybuzz -

Is Aclarion Inc Equity Warrant still a buy after recent gainsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn

Aclarion, Inc. to Engage with Investors at the 38th Annual ROTH Conference Regarding Nociscan Advancements - Quiver Quantitative

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet - Bitget

Aclarion Inc (ACON) 재무 분석

매출

순이익

현금흐름

주당 순 이익

ACON과 유사한 종목